NovaBay Pharmaceuticals, Inc.

1.2000-0.06 (-4.76%)
Oct 29, 4:00:00 PM EDT · NYSE American · NBY · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
7.21M
P/E (TTM)
0.52
Basic EPS (TTM)
2.30
Dividend Yield
0%

Recent Filings

About

NovaBay Pharmaceuticals, Inc. does not have significant operations. Previously, the company was engaged in the development and sale of eyecare, wound care, and skin care products in the United States and internationally. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

CEO
Mr. Tommy Law
IPO
10/26/2007
Employees
13
Sector
Healthcare
Industry
Biotechnology